Clive Ballard, professor of age related disease at the University of Exeter, said that an important take home message was how few trials of drugs for dementia there are. “If you look at ongoing trials of treatment for cancer there are 2000 to 4000, but if you look at Alzheimer’s disease it is more like between 25 and 100. We need a huge increase in the number of trials,” he told a press briefing in London.
This is why I think we need to read as much as possible about preventing alzheimer’s. Lots of scientists have written much about such.